Creu de Sant Jordi awarded to pharmaceutical company Hipra
The biotechnical pharmaceutical company Hipra has received the Creu de Sant Jordi for its commitment to global health, its over 50-year history working in prevention, and its contribution to research to find a new recombinant vaccine for Covid-19, a project the company’s R&D centre at the Barcelona Science Park took part in.
This Monday, President of the Government of Catalonia Pere Aragonès has presided over the awards ceremony recognising 20 figures and 10 organisations from all over Catalonia at the Teatre Monumental in Mataró.
Hipra is a biotechnology pharmaceutical company focused on prevention for human and animal health, with a wide range of highly innovative vaccines and advanced diagnostics service.
Traditionally focused on research, production and commercialisation of vaccines for farm animals, the company has its headquarters in Amer and subsidiaries in various countries in Europe, Asia and Africa. It has 2,500 employees and is currently the sixth largest veterinary vaccine manufacturer in the world.
With the Covid-19 pandemic, the Catalan multinational corporation moved into the human health sector, making itself available to healthcare authorities through various actions, such as processing PCR tests for healthcare centres. In this new phase, Hipra has started to develop a vaccine for the disease caused by the SARS-CoV-2 virus, which is currently in the final stage of trials with very satisfactory results.
The Creu de Sant Jordi is one of the highest honours a person or organisation can receive from the Government of Catalonia. It was established in 1981 to recognise individuals and legal entities who, through their own merit, have served Catalonia notably. Any citizen, group of citizens or organisation can request this award be granted to any individual or legal entity.